Clay B. Siegall
2013
In 2013, Clay B. Siegall earned a total compensation of $6.3M as President and CEO at Seattle Genetics, a 13% increase compared to previous year.
Compensation breakdown
| Bonus | $1,500 |
|---|---|
| Non-Equity Incentive Plan | $652,000 |
| Option Awards | $2,644,713 |
| Salary | $722,917 |
| Stock Awards | $2,257,200 |
| Other | $8,130 |
| Total | $6,286,460 |
Siegall received $2.6M in option awards, accounting for 42% of the total pay in 2013.
Siegall also received $1.5K in bonus, $652K in non-equity incentive plan, $722.9K in salary, $2.3M in stock awards and $8.1K in other compensation.
Rankings
In 2013, Clay B. Siegall's compensation ranked 928th out of 12,286 executives tracked by ExecPay. In other words, Siegall earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 928 out of 12,286 | 92nd |
Division Manufacturing | 306 out of 4,612 | 93rd |
Major group Chemicals And Allied Products | 82 out of 1,462 | 94th |
Industry group Drugs | 49 out of 1,156 | 96th |
Industry Biological Products, Except Diagnostic Substances | 5 out of 196 | 97th |
Source: SEC filing on April 6, 2016.
Siegall's colleagues
We found five more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2013.
2013
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2013
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2013
Todd Simpson
Seattle Genetics
Chief Financial Officer
2013
Vaughn Himes
Seattle Genetics
EVP, Technical Operations
2013
Christopher Boerner
Seattle Genetics